72 - The Antifungal Evolution: Novel Strategies for a Changing World

Thursday, October 12, 2023

1:45 PM – 3:00 PM US ET

Location: 156 ABC

All relevant financial disclosures have been mitigated.

Moderator(s)

Jeniel Nett, MD, PhD

Associate Professor
University of Wisconsin-Madison
Madison, WI, United States
SK

Sophia Koo, MD, SM

Assistant Professor of Medicine
Brigham and Women's Hospital, Dana-Farber Cancer Institute
Boston, MA, United States

Slides

Faculty(s)

Dimitrios Kontoyiannis, MD

Professor, Infectious Diseases
Infectious Diseases, Infection Control and Employee Health
The University of Texas MD Anderson Cancer Center
Houston, TX, United States

Slides
Stuart Levitz, MD (he/him/his)

Professor of Medicine
University of Massachusetts Chan School of Medicine
Worcester, Massachusetts, United States

Slides

Disclosure(s):

Jeniel E. Nett, MD, PhD: No financial relationships to disclose

Sophia Koo, MD, SM: Aerium Therapeutics: Advisor/Consultant (); GSK: Grant/Research Support (); Merck: Grant/Research Support (); Scynexis: Grant/Research Support ()

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe evolving approaches to diagnose fungal infections;
explain novel host-based approaches to prevent and treat invasive fungal infections

Presentations:

1:45 PM – 2:10 PM US ET

Breath-Based Metabolomics for Diagnosis of Invasive Fungal Infections
Speaker: Sophia Koo, MD, SM – Brigham and Women's Hospital, Dana-Farber Cancer Institute
2:10 PM – 2:35 PM US ET

Engineering CAR T and Natural Killer Cells to Treat Mold Infections: Promises and Challenges
Speaker: Dimitrios P. Kontoyiannis, MD – The University of Texas MD Anderson Cancer Center
2:35 PM – 3:00 PM US ET

Antifungal Vaccines: Where Are We At?
Speaker: Stuart M. Levitz, MD (he/him/his) – University of Massachusetts Chan School of Medicine